LV12315B - RISPERIDON BASIC - Google Patents
RISPERIDON BASIC Download PDFInfo
- Publication number
- LV12315B LV12315B LVP-99-32A LV990032A LV12315B LV 12315 B LV12315 B LV 12315B LV 990032 A LV990032 A LV 990032A LV 12315 B LV12315 B LV 12315B
- Authority
- LV
- Latvia
- Prior art keywords
- risperidone
- pamoate
- composition
- composition according
- compound according
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/105—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
- C07C65/11—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing two rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93201216 | 1993-04-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
LV12315A LV12315A (lv) | 1999-07-20 |
LV12315B true LV12315B (en) | 2000-03-20 |
Family
ID=8213799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-99-32A LV12315B (en) | 1993-04-28 | 1999-02-24 | RISPERIDON BASIC |
Country Status (32)
Country | Link |
---|---|
US (2) | US5612346A (zh) |
EP (1) | EP0697019B1 (zh) |
JP (1) | JP3478397B2 (zh) |
KR (1) | KR100307101B1 (zh) |
CN (1) | CN1041727C (zh) |
AT (1) | ATE163418T1 (zh) |
AU (1) | AU675136B2 (zh) |
BG (1) | BG62004B1 (zh) |
CA (1) | CA2160366C (zh) |
CY (1) | CY2107B1 (zh) |
CZ (1) | CZ286688B6 (zh) |
DE (1) | DE69408666T2 (zh) |
DK (1) | DK0697019T3 (zh) |
ES (1) | ES2113652T3 (zh) |
FI (1) | FI109125B (zh) |
GR (1) | GR3026028T3 (zh) |
HK (1) | HK1006059A1 (zh) |
HU (1) | HU218212B (zh) |
IL (1) | IL109448A (zh) |
LV (1) | LV12315B (zh) |
NO (1) | NO305083B1 (zh) |
NZ (1) | NZ266143A (zh) |
PH (1) | PH30476A (zh) |
PL (1) | PL182466B1 (zh) |
RO (1) | RO115955B1 (zh) |
RU (1) | RU2131428C1 (zh) |
SG (1) | SG47046A1 (zh) |
SI (1) | SI9420031B (zh) |
SK (1) | SK280589B6 (zh) |
TW (1) | TW376319B (zh) |
WO (1) | WO1994025460A1 (zh) |
ZA (1) | ZA942909B (zh) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100354270B1 (ko) * | 1993-11-19 | 2003-02-11 | 알커메스 컨트롤드 테라포이틱스 인코퍼레이티드 Ii | 마이크로캡슐화된3-피페리디닐-치환된1,2-벤즈이속사졸및1,2-벤즈이소티아졸 |
US5453425A (en) * | 1994-07-11 | 1995-09-26 | Janssen Pharmaceutica N.V. | Risperidone oral formulation |
TW487572B (en) * | 1996-05-20 | 2002-05-21 | Janssen Pharmaceutica Nv | Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters |
CA2304568C (en) * | 1997-09-30 | 2008-08-12 | Eli Lilly And Company | Olanzapine pamoate formulations |
US6617321B2 (en) | 1997-09-30 | 2003-09-09 | Eli Lilly And Company | 2-methyl-thieno-benzodiazepine formulation |
UA72189C2 (uk) | 1997-11-17 | 2005-02-15 | Янссен Фармацевтика Н.В. | Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот |
HU227400B1 (en) * | 1998-09-30 | 2011-05-30 | Lilly Co Eli | 2-methyl-thieno-benzodiazepine formulation and its use |
WO2000027849A2 (en) * | 1998-11-12 | 2000-05-18 | Merck & Co., Inc. | Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same |
FR2802101B1 (fr) | 1999-12-10 | 2003-02-28 | Aventis Pharma Sa | Association de cymemazine et d'un neuroleptique atypique |
US6770478B2 (en) * | 2000-02-10 | 2004-08-03 | The Regents Of The University Of California | Erythrocytic cells and method for preserving cells |
US6495164B1 (en) * | 2000-05-25 | 2002-12-17 | Alkermes Controlled Therapeutics, Inc. I | Preparation of injectable suspensions having improved injectability |
WO2002043766A1 (fr) * | 2000-11-29 | 2002-06-06 | Takeda Chemical Industries, Ltd. | Compositions medicinales et leur procede de preparation |
US20050232995A1 (en) | 2002-07-29 | 2005-10-20 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
EP1534288A1 (en) * | 2002-08-23 | 2005-06-01 | Ranbaxy Laboratories, Ltd. | Stable aqueous solutions of risperidone and methods for their preparation |
KR20040034996A (ko) * | 2002-10-18 | 2004-04-29 | 한미약품 주식회사 | 리스페리돈의 개선된 제조방법 |
WO2004094415A1 (en) * | 2003-04-22 | 2004-11-04 | Synthon B.V. | Risperidone monohydrochloride |
US6987111B2 (en) * | 2003-08-06 | 2006-01-17 | Alkermes Controlled Therapeutics, Ii | Aripiprazole, olanzapine and haloperidol pamoate salts |
CN1870980B (zh) | 2003-10-23 | 2010-06-23 | 大冢制药株式会社 | 控释无菌阿立哌唑注射剂和方法 |
WO2005053796A1 (en) * | 2003-12-02 | 2005-06-16 | B & B Beheer Nv | Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists |
US7884096B2 (en) * | 2003-12-02 | 2011-02-08 | Pharmaneuroboost N.V. | Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
CA2554959A1 (en) * | 2004-01-29 | 2005-08-11 | Neuromolecular, Inc. | Combination of a nmda receptor antagonist and a mao-inhibitor or a gadpf-inhibitor for the treatment of central nervous system-related conditions |
PT1838716E (pt) * | 2005-01-05 | 2011-07-15 | Lilly Co Eli | Di-hidrato de pamoato de olanzapina |
EP1695973A1 (en) * | 2005-02-24 | 2006-08-30 | Neuro3D | Ocaperidone salt and pharmaceutical compositions containing the same |
AR055099A1 (es) * | 2005-07-28 | 2007-08-08 | Alza Corp | Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol |
WO2007035348A2 (en) * | 2005-09-15 | 2007-03-29 | Elan Pharma International, Limited | Nanoparticulate aripiprazole formulations |
US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
NZ581862A (en) | 2007-05-25 | 2012-06-29 | Tolmar Therapeutics Inc | Injectable subcutaneous formulation comprising risperidone capable of forming a solid, microporous implant in a patient |
US9457026B2 (en) * | 2007-07-31 | 2016-10-04 | Otsuka Pharmaceutical Co., Ltd. | Methods for producing aripiprazole suspension and freeze-dried formulation |
LT2234617T (lt) * | 2007-12-19 | 2021-05-25 | Janssen Pharmaceutica Nv | Dozės režimai, susiję su ilgo veikimo injekuojamais paliperidono esteriais |
PL2685979T3 (pl) | 2011-03-18 | 2017-02-28 | Alkermes Pharma Ireland Limited | Kompozycje farmaceutyczne do wstrzykiwania zawierające środek nierozpuszczalny w wodzie, środek przeciwpsychotyczny, laurynian sorbitanu i polisorbat 20 |
ES2564973T3 (es) | 2011-04-26 | 2016-03-30 | Torrent Pharmaceuticals Limited | Sales por adición de ácidos de risperidona y composiciones farmacéuticas de las mismas |
JP6333802B2 (ja) * | 2012-03-19 | 2018-05-30 | アルカームス ファーマ アイルランド リミテッド | ベンジルアルコールを含む医薬組成物 |
ES2765036T3 (es) | 2012-03-19 | 2020-06-05 | Alkermes Pharma Ireland Ltd | Composiciones farmacéuticas que comprenden esteres de ácidos grasos |
US9993556B2 (en) | 2012-03-19 | 2018-06-12 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions comprising fatty glycerol esters |
WO2013150055A1 (en) | 2012-04-04 | 2013-10-10 | Intervet International B.V. | Solid oral pharmaceutical compositions for isoxazoline compounds |
CN102659577B (zh) * | 2012-04-07 | 2014-07-02 | 安徽绩溪县徽煌化工有限公司 | 一种亚甲基双羟基萘酸的制备方法 |
CA2885196C (en) | 2012-09-19 | 2021-06-22 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions having improved storage stability |
EP2900270B1 (en) * | 2012-09-26 | 2019-03-06 | Tangent Reprofiling Limited | Combination of benzo(iso)oxazolepiperidines with conjugated linoleic acid |
US9375433B2 (en) | 2012-09-26 | 2016-06-28 | Tangent Reprofiling Limited | Modulators of androgen synthesis |
RU2688233C2 (ru) | 2014-03-20 | 2019-05-21 | Алкермес Фарма Айэленд Лимитед | Препараты арипипразола, имеющие повышенные скорости впрыска |
CN106831594B (zh) * | 2017-01-18 | 2018-02-02 | 力赛生物医药科技(厦门)有限公司 | 可乐定双羟萘酸盐及其制备方法 |
WO2019173230A1 (en) | 2018-03-05 | 2019-09-12 | Alkermes Pharma Ireland Limited | Aripiprazole dosing strategy |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4804663A (en) * | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
-
1994
- 1994-03-31 TW TW083102808A patent/TW376319B/zh not_active IP Right Cessation
- 1994-04-08 PH PH48074A patent/PH30476A/en unknown
- 1994-04-22 CA CA002160366A patent/CA2160366C/en not_active Expired - Lifetime
- 1994-04-22 PL PL94311282A patent/PL182466B1/pl unknown
- 1994-04-22 AT AT94915538T patent/ATE163418T1/de active
- 1994-04-22 SG SG1996004131A patent/SG47046A1/en unknown
- 1994-04-22 SK SK1313-95A patent/SK280589B6/sk not_active IP Right Cessation
- 1994-04-22 KR KR1019950704171A patent/KR100307101B1/ko not_active IP Right Cessation
- 1994-04-22 EP EP94915538A patent/EP0697019B1/en not_active Expired - Lifetime
- 1994-04-22 NZ NZ266143A patent/NZ266143A/en not_active IP Right Cessation
- 1994-04-22 RO RO95-01879A patent/RO115955B1/ro unknown
- 1994-04-22 SI SI9420031A patent/SI9420031B/sl unknown
- 1994-04-22 CN CN94191934A patent/CN1041727C/zh not_active Expired - Lifetime
- 1994-04-22 ES ES94915538T patent/ES2113652T3/es not_active Expired - Lifetime
- 1994-04-22 JP JP52386294A patent/JP3478397B2/ja not_active Expired - Lifetime
- 1994-04-22 AU AU67216/94A patent/AU675136B2/en not_active Expired
- 1994-04-22 US US08/522,422 patent/US5612346A/en not_active Expired - Lifetime
- 1994-04-22 DK DK94915538T patent/DK0697019T3/da active
- 1994-04-22 RU RU95119831A patent/RU2131428C1/ru active
- 1994-04-22 DE DE69408666T patent/DE69408666T2/de not_active Expired - Lifetime
- 1994-04-22 WO PCT/EP1994/001296 patent/WO1994025460A1/en active IP Right Grant
- 1994-04-22 HU HU9501934A patent/HU218212B/hu unknown
- 1994-04-22 CZ CZ19952706A patent/CZ286688B6/cs not_active IP Right Cessation
- 1994-04-26 ZA ZA942909A patent/ZA942909B/xx unknown
- 1994-04-27 IL IL109448A patent/IL109448A/xx not_active IP Right Cessation
-
1995
- 1995-10-25 BG BG100094A patent/BG62004B1/bg unknown
- 1995-10-26 NO NO954275A patent/NO305083B1/no not_active IP Right Cessation
- 1995-10-27 FI FI955166A patent/FI109125B/fi not_active IP Right Cessation
-
1996
- 1996-12-24 US US08/773,737 patent/US5723467A/en not_active Expired - Lifetime
-
1998
- 1998-02-26 GR GR980400198T patent/GR3026028T3/el unknown
- 1998-06-11 HK HK98105164A patent/HK1006059A1/xx not_active IP Right Cessation
- 1998-06-16 CY CY9800009A patent/CY2107B1/xx unknown
-
1999
- 1999-02-24 LV LVP-99-32A patent/LV12315B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LV12315B (en) | RISPERIDON BASIC | |
US4725691A (en) | 2-[8-quinolinyl]-sulphinyl-1H-benzimidazole | |
PL188908B1 (pl) | Nowe pochodne benzimidazolu i ich zastosowanie dowytwarzania leków do leczenia stanów alergicznych | |
US3399201A (en) | Aminoalkyl-ethano-anthracenes | |
DE60112254T2 (de) | Benzthiazolderivate die tnf und pde-iv hemmen | |
GB1561561A (en) | Bis (i-phenoxyalkane carboxylic acids) and derivatives thereof process for their preparation and their use as medicaments | |
LV10868B (en) | Oxadiazolyl-alkyl-purine derivatives | |
EP0089028B1 (de) | Neue Theophyllin-Derivate und Verfahren zu ihrer Herstellung | |
JPH0568476B2 (zh) | ||
RU2459824C2 (ru) | Новые соединения для лечения психических расстройств, их получение и применение | |
JPS5874678A (ja) | チアキサンテン誘導体のアルフア異性体のエステルと該エステルの酸附加塩とを製造し且つ精製する方法 | |
GB2081708A (en) | Novel derivatives of (1-benzyl-1h-indazol-3-yl) oxyacetic acid and pharmaceutical composition containing it | |
US3632653A (en) | Ethano-anthracenes | |
US5883255A (en) | Substituted indolizino 1,2-b!quinolinones | |
US3489799A (en) | Ethano-anthracenes | |
JPS6222992B2 (zh) | ||
CZ380596A3 (en) | Salts of 2-(2,6-dichlorophenyl)amino)phenylacetoxyacetic acid with cations of organic bases, process of their preparation, pharmaceutical compositions containing thereof and their use | |
IE42161B1 (en) | Pyrano-quinoline carboxylic acids,processes for their preparation and their use as pharmaceutical agents | |
AU614757B2 (en) | Hydroquinonylphenyl butyric acid amide derivative | |
JPH0559053A (ja) | インドールアルカロイド化合物 | |
JP3029870B2 (ja) | キノリン誘導体 | |
KR800001144B1 (ko) | 2-(4-페닐-4-시아노부틸)-1,2,3,4-테트라하이드로-5(H)-피리도-[4,3-b]-인돌의 제조방법 | |
JPH0368576A (ja) | 薬学的に活性な2―置換された3―(2―エトキシエチル)イミダゾ〔4,5―b〕ピリジンおよび該化合物を含有する薬学的組成物 |